Buccal Infiltration of Different Volumes of Articaine for Extraction.

Launched by QASSIM UNIVERSITY · Oct 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how effective two different amounts of a numbing medication called Articaine are for tooth extractions in the back of the jaw. The trial will compare using either 1.8 ml or 3.6 ml of this medication to see which volume works better for making patients comfortable during the procedure. The trial is not yet recruiting participants but aims to include healthy individuals aged 18 and older who need to have certain back teeth removed due to decay or other reasons.

To be eligible for this trial, participants should not have any serious health issues and must not be allergic to the medications used. They should also not have any infections at the extraction site or be pregnant. Those who participate can expect to receive either of the two doses of Articaine before their tooth extraction and help researchers understand which dose provides better pain relief. This information could help improve dental procedures for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All healthy patients (ASA I) or patients with mild systemic disease with no functional limitations (ASA II)
• • Patients aged ≥ 18 years of age.
• • Patients requiring extraction of mandibular posterior teeth including grossly decayed tooth, grade I mobile tooth, root stumps and indicated for therapeutic reasons.
• • Patients not allergic to the drugs or anesthetic agents used in the surgery.
• Exclusion Criteria:
• • Acute infection at the extraction site.
• • Patients indicated for surgical extraction of teeth.
• • Patients already taking medications affecting pain assessment.
• • Pregnant patients.